Immediate Impact
57 standout
Citing Papers
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
2024 Standout
Glioblastoma Therapy: Past, Present and Future
2024 Standout
Works of G. Fleischhack being referenced
Results of a phase II trial of h-R3 monoclonal antibody (nimotuzumab) in the treatment of resistant or relapsed high-grade gliomas in children and adolescents
2006
Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| G. Fleischhack | 110 | 71 | 73 | 102 | 17 | 386 | |
| Myke R. Green | 150 | 47 | 40 | 74 | 22 | 384 | |
| Andreas Beilken | 110 | 42 | 81 | 59 | 21 | 442 | |
| Boyd A. Nies | 101 | 62 | 121 | 98 | 10 | 369 | |
| V. Rodriguez | 162 | 111 | 119 | 64 | 18 | 393 | |
| Sergio Mecarocci | 187 | 83 | 115 | 52 | 21 | 424 | |
| W. Mark Roberts | 69 | 23 | 177 | 140 | 16 | 400 | |
| Francesca Scuderi | 209 | 63 | 44 | 29 | 18 | 394 | |
| Hugh M. Clink | 144 | 56 | 104 | 49 | 23 | 435 | |
| Ka Wah Chan | 106 | 40 | 174 | 49 | 10 | 349 | |
| Michael Friedland | 99 | 33 | 52 | 48 | 24 | 389 |
All Works
Loading papers...